San Diego, CA, United States of America

Robert Paul Morse

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Paul Morse. Retrieved from https://idiyas.com/inventor/robert-paul-morse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Paul Morse

Introduction

Robert Paul Morse is a notable inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly through his work on Tie2-binding agents. His innovative approach has led to advancements in medical treatments and therapies.

Latest Patents

Robert Paul Morse holds a patent for Tie2-binding agents and methods of use. This invention provides Tie-2 antibodies and fragments thereof, along with conjugates and methods for utilizing these agents. His work in this area has the potential to impact various therapeutic applications.

Career Highlights

Morse is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Minhong Yan and Gu Zhang. Their combined expertise enhances the research environment at Genentech, fostering innovation and the development of new therapies.

Conclusion

Robert Paul Morse's contributions to biotechnology through his patent and work at Genentech exemplify the impact of innovation in the medical field. His dedication to advancing science continues to inspire future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…